Document is current

Article History

Received: 10 October 2023

Accepted: 6 March 2024

First Online: 8 April 2024

Declarations

:

: MC has received honoraria and travel grants from AMGEN and DKSH for speaking engagements outside the submitted work.KEA has received speaker fees from Amgen, Astellas Pharma, Chugai, and UCB outside the submitted work.MKJ has received honoraria, unrestricted research grants, and travel and/or subsistence expenses from Amgen, Lilly UK, Internis, Consilient Health, Zebra Medical Vision, Kyowa Kirin Hakin, and UCB outside the submitted work.NCH reports personal fees, consultancy, lecture fees, and honoraria from Alliance for Better Bone Health, AMGEN, MSD, Eli Lilly, Servier, Shire, UCB, Kyowa Kirin, Consilient Healthcare, Theramex, and Internis Pharma, outside the submitted work.RDB serves on an advisory board for Amgen, has received royalties from Wolters-Kluwer, and has ownership/stock interests in Abbott Labs, Abbvie, Amgen, Doctorpedia, Glaxo, JangoBio, Johnson & Johnson, Procter & Gamble, and ROMTech outside the submitted work.MLB has served as a consultant for Aboca, Alexion, Amolyt, Bruno Farmaceutici, Calcilytix, Echolight, Kyowa Kirin, Personal Genomics, and Smoke-Free World Foundation; has received honoraria from Amgen, Bruno Farmaceutici, Calcilytix, Kyowa Kirin, and UCB; and received grants from Abiogen, Alexion, Amgen, Amorphical, Bruno Farmaceutici, CGeDi, Echolight, Eli Lilly, Enterabio, Gedeon Richter, Italfarmaco, Kyowa Kirin, Menarini, Monter Rosa Therapeutics, SPA, Takeda, Thermax, and UCB outside the submitted work.TC has no conflict of interest to disclose.GPL has no conflict of interest to disclose.PΜ reports fees for lectures/advisory boards and research grants from Amgen and Galenica and fees for lectures/advisory boards and conference travel from UCB, Elpen, Bianex, and Eli-Lilly outside the submitted work.JP has no conflict of interest to disclose.PC has no conflict of interest to disclose.DP has no conflict of interest to disclose.MS has no conflict of interest to disclose.TT has received consultancy/speaker’s fees from AMGEN, Arrow, Biogen, Chugai, Expanscience, Grunenthal, Jansen, LCA, Lilly, MSD, Nordic, Novartis, Pfizer, Sanofi, Thuasne, Theramex, TEVA, and UCB and financial support or fees for research activities from Bone Therapeutics, Chugai, and UCB outside the submitted work.SS reports consultancy fees from Radius, Amgen, Lilly, and Pfizer and grants from Amgen outside the submitted work.